Cargando…
达雷妥尤单抗治疗复发/难治多发性骨髓瘤的疗效与安全性
OBJECTIVE: To investigate the efficacy and safety of daratumumab in relapsed and refractory multiple myeloma (RRMM). METHODS: The clinical characteristics, adverse reactions, efficacy, and prognosis of 46 patients with RRMM treated with daratumumab in Shanghai Changzheng Hospital from September 2017...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957251/ https://www.ncbi.nlm.nih.gov/pubmed/33677865 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.01.006 |